Medical Oncologist
Metastatic breast cancer
Lines of treatment in metastatic breast cancer: a map
Metastatic breast cancer is usually treated in a series of steps called lines. Each continues while it controls the cancer, and the order depends on cancer type, past treatment and your health. More options usually remain when one stops working. This page maps the journey.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What are lines of treatment in metastatic breast cancer?
- Factors that decide the order of treatment
- Typical treatment families by cancer type
- The vocabulary, in plain language
- Honest expectations across treatment lines
- What happens when a treatment stops working
- Living well through many lines of treatment
- Questions to ask about your treatment map
- Supporting someone through changing treatments
- What people assume about treatment lines
- Common questions about lines of treatment
The short answer
What are lines of treatment in metastatic breast cancer?
In metastatic breast cancer, treatment is usually given as a series of steps called lines. First-line treatment is the first treatment given after metastatic cancer is diagnosed. When that treatment stops controlling the cancer, or causes side effects that are too difficult, a second-line treatment is started, then a third, and so on. Each line may be a single medicine or a combination, and it continues for as long as it keeps the cancer under control and side effects are manageable, which may be months or several years. The order is planned so that the treatments most likely to work well, with the best balance of benefit and side effects, are generally used earlier. The choice at each step depends mainly on the cancer's type, especially hormone receptors and HER2, which treatments you have already had and how well they worked, how quickly the cancer is growing, whether vital organs are affected, genetic changes found in the cancer or inherited genes, your overall health and your own priorities. Thinking of treatment as a map, rather than a single decision, helps many people understand that more options usually remain when one treatment stops working.
Treatment is often continuous
Unlike early breast cancer, where treatment has a set end date, metastatic treatment usually continues as long as it helps, with breaks sometimes possible.
Scans guide each change
Regular scans, symptoms and sometimes blood tests show whether a line is still working, and the next line is planned when it is not.
Your priorities matter
Quality of life, side effects, travel for treatment and cost are all part of the conversation at every step.
This page gives general information only. Your oncologist will plan the sequence that suits you.What shapes the map
Factors that decide the order of treatment
Your team considers these together at every step.
Cancer type
Hormone receptor positive, HER2-positive, HER2-low and triple negative cancers each follow different sequences.
Previous treatment
What you received for early breast cancer, and how long ago, affects what is likely to work now.
How fast the cancer is moving
Rapid growth or organs under strain may call for a faster-acting treatment.
This is sometimes called visceral crisis.Genetic findings
Changes in the cancer or inherited genes can open targeted options.
Also considered
- Your general health and other conditions
- Side effects you want to avoid
- Access, travel and cost
A general map
Typical treatment families by cancer type
Cancer type
Treatment families commonly used across lines
Hormone receptor positive, HER2-negative
Hormone therapy with targeted tablets first, then other hormone and targeted options, then chemotherapy or antibody-drug conjugates
HER2-positive
HER2-targeted antibodies with chemotherapy, then HER2 antibody-drug conjugates, then HER2 tablets and other combinations
HER2-low
Standard options for the receptor type, with an antibody-drug conjugate for HER2-low cancer in later lines
Triple negative
Chemotherapy, with immunotherapy for some, then antibody-drug conjugates and PARP inhibitors for BRCA carriers
Not sure whether this applies to you?
Ask an oncologistWords you will hear
The vocabulary, in plain language
- Line of treatment
- One step in the sequence of treatments for metastatic cancer.
- Progression
- When cancer grows or spreads despite treatment.
- Endocrine resistance
- When hormone-sensitive cancer stops responding to hormone therapy.
- Antibody-drug conjugate
- An antibody that carries chemotherapy directly to cancer cells.
- Maintenance treatment
- Gentler treatment continued after a good response to keep cancer under control.
- Treatment break
- A planned pause from treatment when cancer is stable, in selected people.
Being straight with you
Honest expectations across treatment lines
Metastatic breast cancer is usually treated as a long-term condition rather than something that goes away completely. Many people live well for years, moving through several lines of treatment.
Each line tends to work for a shorter time
On average, later lines control cancer for shorter periods than earlier ones, though individual experiences vary widely, and some people respond well to later treatments.
Side effects add up
Tiredness, numbness or reduced blood counts from earlier treatments can influence what is suitable later.
Access to newer medicines varies
Some newer options may be costly or not yet widely available. Ask your team about access programmes and clinical trials.
Stopping active treatment is a choice too
At some point, focusing on comfort and quality of life may be the right decision. Palliative care can support you at every stage, not only at the end.
What this page cannot tell you
It cannot map your own sequence. Ask your oncologist what comes next for you.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Moving to the next line
What happens when a treatment stops working
Hearing that a treatment has stopped working is hard news. Your team follows a careful process to plan the next step.
Confirming progression
Scans are reviewed alongside symptoms and blood tests. Sometimes a scan is repeated to be sure a change is real.
Considering a new biopsy
A biopsy of a growing area can recheck receptors and look for genetic changes that open targeted options.
Reviewing your health and wishes
Your energy, side effects, work, family needs and preferences shape which option suits you best.
Local treatment for single growing spots
If only one area grows while others stay controlled, radiation to that spot may let you continue the current treatment.
Starting the new line
Your team explains the schedule, side effects and when the first scan will check response.
Daily life
Living well through many lines of treatment
Long-term treatment becomes part of daily life. Planning and support make it easier to keep doing what matters.
Build treatment around your life
Ask whether appointment times, tablet schedules or treatment breaks can fit around work, festivals, travel or family events.
Report side effects early
Dose adjustments or supportive medicines can often keep a helpful treatment going longer.
Keep a treatment record
A simple list of each line, when it started and stopped, and major side effects helps new doctors and second opinions.
Involve palliative care early
Palliative care teams help with pain, tiredness, mood and planning, alongside active cancer treatment.
At your appointment
Questions to ask about your treatment map
Written questions help you understand both the current step and the path ahead.
About the current line
Why is this treatment recommended now? How will we know it is working? What side effects should I watch for?
About what comes next
If this stops working, what options are likely? Should my cancer have genetic testing now, so we are ready?
About trials and access
Are there clinical trials or access programmes I could consider at any stage?
For families
Supporting someone through changing treatments
Each change of treatment brings new schedules, side effects and emotions for the whole family, and relatives often carry much of the practical load.
Help keep track
Keep a shared record of treatments, dates, side effects and questions, and bring it to appointments so nothing is missed.
Listen to their priorities
Some people want every possible option, while others value time at home and fewer side effects. Supporting their choices matters.
Look after yourself
Caring over many months or years is tiring. Share tasks and seek support for yourself as well.
Commonly believed
What people assume about treatment lines
If first-line treatment fails, nothing else will work.
Most people have several further options after first-line treatment.
The strongest treatment should always come first.
The best order balances benefit, side effects and cancer type.
Treatment stops after a fixed number of cycles.
Metastatic treatment usually continues while it helps.
Palliative care means giving up.
Palliative care supports comfort alongside active treatment.
Questions we are asked
Common questions about lines of treatment
How many lines of treatment are there?
There is no fixed number. Many people receive several lines over years, depending on response and health.
How long does each line last?
As long as it controls the cancer with manageable side effects, from months to years.
Can I go back to an earlier treatment?
Sometimes, especially if it worked well and was stopped for reasons other than progression.
Can I take a break from treatment?
In selected situations, with close monitoring. Ask your oncologist.
When is a clinical trial worth considering?
At any line. Ask early, as some trials need specific timing.
Does changing treatment mean the end is near?
No. Changing lines is a normal part of long-term care.
Can I get a second opinion?
Yes. Bring your treatment record, scans and pathology.
Who plans the sequence?
Your oncologist, together with you and the wider team.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- European Society for Medical Oncology — Metastatic breast cancer clinical practice guideline
- National Comprehensive Cancer Network — Patient guidelines: metastatic breast cancer
- National Cancer Institute — Breast cancer treatment (PDQ)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.